Xiromed SA - Abirateron Xiromed 500 mg, Filmtabletten | | 68482 | | 01 | | Abirateron Xiromed 500 mg | | Filmtabletten | | L02BX03 | | Abiraterone | | 21.12.2022 | | |
| Composition | abirateroni acetas 500 mg, carmellosum natricum conexum, lactosum monohydricum 258.9 mg, natrii laurilsulfas, hypromellosum, cellulosum microcristallinum silicificatum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), titanii dioxidum, macrogolum 3350, talcum, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto corresp. natrium 11.99 mg. | Packungsbestandteile | | Comprimés filmés | | Principe actif | Concentr. |
---|
Abirateroni Acetas | 500 mg |
| | Agents auxilliaires | Concentr. | informations additionels |
---|
(Flavum) | | | (Nigrum) | | | (Rubrum) | | | Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum Silicificatum | | | E 172 | | color. | Hypromellosum | | | Lactose Monohydrate | 258.9 mg | | Macrogol | 3350 | | Magnesii Stearas | | | Natrii Laurilsulfas | | | Poly(Alcohol Vinylicus) | | Überzug | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | | Talcum | | | Titanium Dioxide | | |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
001 | 56 | DDP | DDP | B | | Oui |
|
|